Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials. Alzforum, 07 Apr 2017 Abushouk AI, Elmaraezy A, Aglan A, Salama R, Fouda S, Fouda R, AlSafadi AM. Bapineuzumab for mild to moderate Alzheimer's…